Effects of Volatile and Intravenous Anesthetics on Pupillary Function

NCT ID: NCT03987529

Last Updated: 2020-08-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

22 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-08-12

Study Completion Date

2021-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To compare of effects of volatile and intravenous anesthetics on pupillary function during general anesthesia in children

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The investigator will measure the pupillary function with pupillometry during general anesthesia with volatile or intravenous anesthetics in children.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pupillary Functions, Abnormal

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Sevoflurane+Remifentanil

Using inhalent agent(Sevoflurane), continuous infusion of Remifentanil

sevoflurane

Intervention Type OTHER

volatile anesthetic

Propofol+Remifentanil

Using continuous infusion of Propofol and Remifentanil

propofol

Intervention Type OTHER

intravenous anesthetic

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

sevoflurane

volatile anesthetic

Intervention Type OTHER

propofol

intravenous anesthetic

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Pediatric patients undergoing general anesthesia

Exclusion Criteria

* If injection of any agents that can change pupil size or index
* Any severe side effects, adverse drug reaction
Minimum Eligible Age

3 Years

Maximum Eligible Age

12 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Seoul National University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hee-Soo Kim

professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Hee-Soo Kim, M.D., Ph.D.

Role: PRINCIPAL_INVESTIGATOR

Seoul National University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Seoul National University Hospital

Seoul, , South Korea

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

South Korea

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Sang-Hwan Ji, M.D., M.S.

Role: CONTACT

+82-2-2072-3661

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Hee-Soo Kim, PhD

Role: primary

+82220723659

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

H1906-096-1040

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Emergence Agitation of Sevoflurane in Pediatric
NCT06830564 COMPLETED PHASE2/PHASE3